AffyImmune Therapeutics
Latest round
- Series A
Last raised
- Oct 2021
Total raised
- $30M
Investors
- 1
About AffyImmune Therapeutics
AffyImmune Therapeutics Inc.Founded in 2016 and based in Natick, US, AffyImmune Therapeutics Inc. specializes in immunotherapy.AffyImmune Therapeutics, Inc. specializes in developing advanced cellular therapies that utilize the patient’s immune system to target and eliminate tumor cells characterized by the overexpression of ICAM-1. Their primary product, AIC100, is an ICAM-1-directed CAR T therapy aimed specifically at patients suffering from anaplastic and advanced differentiated thyroid cancers. The innovative technology enhances CAR T cell affinity, allowing for the selective destruction of tumor cells while preserving healthy tissue.AffyImmune Therapeutics, Inc. has a revenue model that relies on partnerships and collaborations with healthcare providers and research institutions. These agreements typically involve the provision of CAR T cell therapies, especially AIC100, to oncologists and hospitals treating advanced thyroid cancers.AffyImmune Therapeutics Inc. The company aims to expand its therapeutic offerings and improve patient outcomes through innovative products, while also exploring new markets for their therapies in regions with high incidences of thyroid cancer. Plans include strategic collaborations and research initiatives to facilitate this growth.
Who invested in AffyImmune Therapeutics
1 investor across 1 round
See all investors in AffyImmune Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 7, 2021
Amount
$30M
Investors
Questions about AffyImmune Therapeutics
Who invested in AffyImmune Therapeutics?
AffyImmune Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AffyImmune Therapeutics raised?
AffyImmune Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AffyImmune Therapeutics last raise money?
AffyImmune Therapeutics's most recent round on record is a Series A, in Oct 2021.
What does AffyImmune Therapeutics do?
AffyImmune Therapeutics is a biotechnology company.
Where is AffyImmune Therapeutics headquartered?
AffyImmune Therapeutics is headquartered in Natick, US.
Which VCs invest in companies like AffyImmune Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AffyImmune Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AffyImmune Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.